About M3

M3 is a one of a kind venture company that operates a multitude of global services centred around its physician platform such as m3.com .

M3 is the first company incorporated after the year 2000 to be included in the Nikkei 225 Index. Its 330,000+ Japanese and 6,500,000+ global physician member panel serves as a central platform in advancing innovation and reform across healthcare worldwide.

Philosophy & Approach

“Making use of the Internet to increase, as much as possible, the number of people who can live longer and healthier lives, and to reduce, as much as possible, the amount of unnecessary medical costs”

- this is both the desire and goal of M3.

We strive to innovate the medical industry through provision of quality medical information for the clinical scene.
Our services and products aim to provide our clients and members with never ending inspiration, exhilaration, and joy.
We hope to provide corporate value for our investors, while inviting concordance with our mission to serve society.
It is important to maintain an enriching work environment that promotes rewarding each team member to grow and flourish, and where one can share a unified purpose with the group, whether they be a professional in medicine, IT, communication, management, and others.
Given there is a limit to what we can do as M3, we wish to continue collaborative efforts with like-minds to actualize advancement in the field of medicine.

Overview

Company Name

M3, Inc.

Established

September 2000

Capital

29,317 million yen (as of end of March, 2024)

Listed Exchange

Tokyo Stock Exchange Prime Market (Securities code 2413)

Employees

649 [12,100 on consolidated basis] (as of end of March, 2024)

Head Office

Akasaka Intercity 10th floor
1-11-44 Akasaka
Minato-ku, Tokyo 107-0052 JAPAN
TEL:+81-3-6229-8900 FAX:+81-3-6229-8922

Nature of Business

Providing medical-related services through the use of the Internet.

Board Members

  • Itaru Tanimura, Representative Director
  • Akihiko Tomaru, Director
  • Eiji Tsuchiya, Director
  • Rie Nakamura, Director
  • Yoshinao Tanaka, Director
  • Satoshi Yamazaki, Director
  • Kenichiro Yoshida, Director
  • Yusuke Tsugawa, Director
  • Mayuka Yamazaki, Director (Audit and Supervisory Committee Member)
  • Takako Ebata, Director (Audit and Supervisory Committee Member)
  • Satoko Suzuki, Director (Audit and Supervisory Committee Member)

Main Subsidiaries

Overseas

Japan

Main Affiliates

M3 Group Code of Conduct

M3 Corporate Governance Report

History

We are promoting various businesses to solve problems in the medical industry.

2000
September

Established So-net M3, Inc. in Tokyo for the purpose to deliver the Internet service focusing on the medical industry

October

Launched "MR-kun", an internet-based communication tool service to support provision of information to physicians by MR (Medical Representatives: pharmaceutical information representatives at pharmaceutical companies)

2003
July

Integrated 2 existing medical information sites, "MyMedipro" and "so-netm3.com", to start operating as a specialized medical site "m3.com"

October

Established So-net M3 USA Corporation (currently M3 USA Corporation) to launch businesses in the U.S.

2004
September

Listed shares on the Mothers Market of the Tokyo Stock Exchange

2005
December

Launched "AskDoctors", the first consumer service

2007
March

Changed listing market to the First Section of the Tokyo Stock Exchange

2009
December

Established M3 Career, Inc. offering job advertisement and agency businesses for physicians and pharmacists

2010
January

Changed the trade name to M3, Inc.

2011
August

Consolidated Doctors.net.uk Limited (currently M3 (EU) Limited) offering a portal site for physicians in the U.K.

November

Moved the headquarters to the current location

2012
October

Consolidated CMS Co., Ltd. (currently M3 Solutions,inc.), offering EHR (Electronic Health Records) and its development and maintenance services, etc.

2013
November

Consolidated Kingyee Co., Limited (currently Medlive Technology Co., Ltd.) which has become an equity method affiliate as of June, 2021 due to its listing on the Hong Kong Stock Exchange

2014
February

Consolidated MEDISCIENCE PLANNING INC. supporting clinical trial operations through stock exchange

August

Established M3 Doctor Support Inc. (currently CUC Inc.) to launch management support business for medical institutions

2016
November

Consolidated AXIO Medical Holdings Limited (currently M3 Medical Holdings LTD), a holding company of Vidal Group, offering drug information database related businesses mainly in France, Germany, and Spain

2018
February

Consolidated Wake Research Holdings, LLC (currently M3 Wake Research, Inc.) offering clinical trial supporting businesses in the U.S.

2019
March

Consolidated DailyRounds, Inc., a holding company of Neuroglia Health Private Limited offering medical education services in India

2021
November

Launched "M3 DigiKar Smart”, a one-stop cloud service that offers consolidated operations in clinics such as appointment managements, consultations and cashless payments, etc.

2022
April

Moved listing market from the First Section to the Prime Market of the Tokyo Stock Exchange due to market reclassification of the Tokyo Stock Exchange

July

Launched “White-Jack Project,” an initiative in the field of preventive medicine to maintain good health from the pre-onset stage of disease

2023
June

Newly listed shares of consolidated subsidiary CUC, Inc. on the Growth Market of the Tokyo Stock Exchange

July

Acquired two healthcare research related businesses mainly in Europe and the U.S. from Kantar Group, offering marketing and data analytics business: Kantar Profiles-Health and Kantar Media Healthcare Research

WHITE JACKVALUE QUARTET
Copyright© M3, Inc. All Rights Reserved.